Insider Transactions in Q4 2022 at Lexaria Bioscience Corp. (LEXX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 14
2022
|
Gregory Downey Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
121
+5.83%
|
$242
$2.09 P/Share
|
|
Oct 13
2022
|
Christopher Bunka Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
16,600
+6.13%
|
$33,200
$2.1 P/Share
|
|
Oct 12
2022
|
Christopher Bunka Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
21,900
+8.43%
|
$21,900
$1.99 P/Share
|